Stimulus-secretion coupling in platelets. Effects of drugs on secretion on adenosine 5'-triphosphate.
The mechanism of stimulus-secretion coupling in platelets was investigated by observing the effects of drugs on the kinetics on ATP secretion induced by either thrombin or the divalent cation ionophore A23187. The actual secretion is the same with either of these agents, since the rate constants and activation energies of secretion are the same and since drugs that affect the final, enzyme-independent steps of thrombin-induced secretion have the same effect on ionophore-induced secretion. Drugs that affect early steps of thrombin-induced secretion have no effect on ionophore-induced secretion. Drugs that act through cAMP (PGE1, theophylline, dibutyryl-cAMP) slow an early step in the mechanism of thrombin-induced secretion and completely block at higher levels, with the required concentration of inhibitor dependent on thrombin concentration. The inhibition of rate appears to be all-or-none, with no intermediate rates observed. By replacing thrombin with trypsin, which makes it possible to observe a complete change in rate-determining step from an enzyme-dependent to an enzyme-independent platelet step, it was found that these drugs slow the rate only when the enzyme-independent step is rate determining. These drugs have no effect on A23187-induced secretion. It was concluded that cAMP inhibits at a step after the enzyme step but before the final step by interfering with transmission of the stimulus-secretion coupling signal. Disruption of microfilament function by cytochalasin B (10 muM) accelerates the rate of secretion induced by either thrombin or ionophore. The microtubule agents colchicine, vinblastine, and vincristine had effects only at concentrations above those usually considered necessary for the specific inhibition of microtubule function. Drugs that inhibit prostaglandin synthesis (aspirin, indomethacin, eicosatetraynoic acid), drugs that block ATP production (antimycin A, deoxyglucose), or several other drugs previously reported to inhibit platelet function had no effect on secretion.
D000255:Adenosine Triphosphate / Q000378:metabolism*; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D003994:Bucladesine; D000001:Calcimycin / Q000494:pharmacology; D002413:Cations, Divalent; D000242:Cyclic AMP / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008870:Microtubules / Q000187:drug effects; D011458:Prostaglandins E / Q000494:pharmacology*; D012636:Secretory Rate / Q000187:drug effects; D013806:Theophylline / Q000494:pharmacology*; D013816:Thermodynamics; D013917:Thrombin / Q000494:pharmacology*; D014357:Trypsin
D002413:Cations, Divalent; D011458:Prostaglandins E; D000001:Calcimycin; D003994:Bucladesine; D000255:Adenosine Triphosphate; D013806:Theophylline; D000242:Cyclic AMP; D014357:Trypsin; D013917:Thrombin